Global Migraine Market Spotlight 2017-2027: Key Pipeline and Marketed Drugs, Clinical Trials, Upcoming and Regulatory Events, and Patent Information

Global Migraine Market Spotlight 2017-2027: Key Pipeline and Marketed Drugs, Clinical Trials, Upcoming and Regulatory Events, and Patent Information

PR Newswire

DUBLIN, Jan. 11, 2018

DUBLIN, Jan. 11, 2018 /PRNewswire/ --

The "Market Spotlight: Migraine" report has been added to Research and Markets' offering.

Research and Markets Logo

This Market Spotlight report covers the Migraine market, comprising key pipeline and marketed drugs, clinical trials, upcoming and regulatory events, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.

Key Takeaways

Key Topics Covered:

1 KEY TAKEAWAYS

2 DISEASE BACKGROUND

3 TREATMENT

4 NSAIDs

5 EPIDEMIOLOGY

6 PIPELINE DRUGS

7 MARKETED DRUGS

8 KEY UPCOMING EVENTS

9 LICENSING AND ASSET ACQUISITION DEALS

10 PARENT PATENTS

11 REVENUE OPPORTUNITY

12 CLINICAL TRIAL LANDSCAPE

13 BIBLIOGRAPHY

14 APPENDIX

For more information about this report visit https://www.researchandmarkets.com/research/8nb85v/global_migraine?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Voltar noticias em Inglês